← Evidence map

ReviewMedComm2025

Metabolic Reprogramming: A Crucial Contributor to Anticancer Drug Resistance.

Yunhan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40919131